期刊文献+

窄谱UVB照射联合匹多莫德治疗白癜风100例临床分析 被引量:5

Clinical Analysis on the Combination of NB-UVB Irradiation and Pidotimod on the Treatment of Vitiligo in 100 Cases
下载PDF
导出
摘要 目的探讨窄谱UVB照射联合匹多莫德治疗白癜风的临床疗效.方法选取100例白癜风患者,随机分为对照组和观察组,每组各50例.对照组患者单纯给予窄谱UVB照射治疗,观察组患者给予窄谱UVB照射联合匹多莫德治疗.结果观察组患者经过治疗,临床疗效总有效率为94.0%(47/50),对照组总有效率为78.0%(39/50),观察组疗效总有效率显著高于对照组,差异具有统计学意义(P<0.05).结论匹多莫德作为一种新型化学合成免疫调节剂,联合窄谱UVB照射应用在白癜风的治疗中,能够有效提高巨噬细胞吞噬能力和趋化性,更好地提高机体细胞免疫功能.窄谱UVB照射联合匹多莫德治疗白癜风效果显著,患者耐受性提高,不良反应发生率低,值得临床推广使用. Objective To explore the clinical curative effect of NB-UVB irradiation combined with pidotimod on the treatment of vitiligo.Method 100 patients with facial and neck vitiligo were selected,and randomly divided into control group and observation group with 50 cases in each group.Patients in the control group were treated with narrow band UVB irradiation,and patients in the observation group were treated with narrow band UVB irradiation combined with pidotimod therapy.Results After treatment,the total effective rate of the observation group was 94.0%(47/50),and the rate of the control group was 78.0%(39/50).The total effective rate of the observation group was significantly higher than that of the control group(P〈0.05).Conclusion As a new chemical synthetic immunomodulator,pidotimod combined with narrow band UVB radiation in the treatment of vitiligo,can effectively improve the phagocytosis ability and chemotaxis of macrophagocyte,and can also better improve cellular immune function.Narrow band UVB radiation combined with pidotimod in the treatment of vitiligo has a significant clinical effect,can improve patient 's tolerance and reduce the incidence of adverse reactions.Thus,it is worth widely spread and use.
作者 李迎
出处 《北华大学学报(自然科学版)》 CAS 2016年第3期384-386,共3页 Journal of Beihua University(Natural Science)
基金 吉林省教育厅科学技术研究项目(2014189)
关键词 白癜风 窄谱UVB照射 匹多莫德 临床疗效 不良反应 vitiligo narrow-band UVB irradiation pidotimod clinical curative effect adverse reactions
  • 相关文献

参考文献10

  • 1Quan C, Ren Y Q, Xiang L H, et al. Genome-wide asso- ciation study for vitiligo identifies susceptibility loci at 6q27 and the MHC [J]. Nat Genet, 2010,42 (7):614-618. 被引量:1
  • 2Bassiouny D A, Shaker O. Role of interleukin-17 in the pathogenesis of vitiligo [ J ]. Clin Exp Demlatol,2011,36 (3) : 292-297. 被引量:1
  • 3Ali R,Ahsan M S,Azad M A,et al. Immunoglobulin levels of vitiligo patients [ J ]. Pak J Pharm Sci, 2010,23 ( 1 ) : 97-102. 被引量:1
  • 4Ezzedine K, Lim H W, Suzuki T, et al. Revised clas- sification/nomen-clature of vitiligo and related issues:the vitiligo global issues consensus conference [ J]. Pigment Cell Melanoma Res ,2012,25 ( 3 ) :E1-E13. 被引量:1
  • 5Wang C Q, Cruz-Inigo A E, Fuentes-Duculan J ,et al. Th17 zells and activated dendritic cells are increased in vitiligo lesions [ J ]. PLoS One,2011,6 (4) : e18907. 被引量:1
  • 6JinY,Birlea S A,FainP R,et al. Variant of TYR and aut- oimmunity susceptibility loci in generalized vitiligo[J]. N Engl J Med,2010,362 (18) : 1686-1697. 被引量:1
  • 7Zhou L,Li K, Shi Y L, et al. Systemic analyses of imm- unopheno types of peripheral T ceils in non-segmental vitiligo : implication of defective natural killer T cells [ J ]. Pigment Cell Melanoma Res,2012,25 (5) :602-611. 被引量:1
  • 8Yang Z, Klionsky D J. Eaten alive: a history of macr- oautophagy[ J]. Nat Cell Biol,2010,12(9) :814-822. 被引量:1
  • 9Deretic V. Autophagy in immunity and cell-autonomous defense against intracellular microbes [J].Immunol Rev, 2011,240( 1 ) :92-104. 被引量:1
  • 10Necmettin Akdeniz, Ibrahim Halil Yavuz, Serap Gunes Bilgili, et al. Comparison of efficacy of narrow band UVB therapies with UVB alone, in combination with calcipotriol, and with betamethasone and calcipotriol in vitiligo[ J ]. Journal of Dermatological Treatment, 2014, 16(3) :153-157. 被引量:1

同被引文献82

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部